Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Postoperative Complications 1Pancreatic Neoplasms 1

Interventions

ferric carboxymaltose 3Radiotherapy 2Proctectomy 2Oxaliplatin 2Exercise 2vapreotide 1ferrous sulfate 1Vitamin D 1Ultrasonography 1Tomography, X-Ray Computed 1Tea 1Surgical Procedures, Operative 1Standard of Care 1Ropivacaine 1Relaxation Therapy 1Psychology 1Plastic Surgery Procedures 1Neoprene 1Neomycin 1Metronidazole 1Leucovorin 1Immunonutrition Diet 1Hepatectomy 1Folfox protocol 1Fluorouracil 1Esophagectomy 1Enteral Nutrition 1Enhanced Recovery After Surgery 1Electroacupuncture 1Docosahexaenoic Acids 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Postoperative Complications × vapreotide × Gastrointestinal × Clear all
NCT00014651 2010-08-10

Vapreotide in Treating Patients Undergoing Elective Pancreatic Resection

Mayo Clinic

Phase 3 Terminated
Gastrointestinal

Pancreatic Neoplasms, Postoperative Complications

Data powered by HemOnc (CC BY 4.0) Colophon âš¡